药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Pipecuronium
Acetyldigoxin
The risk or severity of QTc prolongation can be increased when Acetyldigoxin is combined with Eliglustat.
Pipecuronium
Delafloxacin
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Eliglustat.
Pipecuronium
Lidoflazine
The risk or severity of QTc prolongation can be increased when Lidoflazine is combined with Eliglustat.
Pipecuronium
Bencyclane
The risk or severity of QTc prolongation can be increased when Bencyclane is combined with Eliglustat.
Pipecuronium
Gallopamil
The risk or severity of QTc prolongation can be increased when Gallopamil is combined with Eliglustat.
Pipecuronium
Tetrahydropalmatine
The risk or severity of QTc prolongation can be increased when Tetrahydropalmatine is combined with Eliglustat.
Pipecuronium
Niguldipine
The risk or severity of QTc prolongation can be increased when Niguldipine is combined with Eliglustat.
Pipecuronium
Lacidipine
The risk or severity of QTc prolongation can be increased when Lacidipine is combined with Eliglustat.
Pipecuronium
Aranidipine
The risk or severity of QTc prolongation can be increased when Aranidipine is combined with Eliglustat.
Pipecuronium
Pinaverium
The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Eliglustat.
Pipecuronium
Trimebutine
The risk or severity of QTc prolongation can be increased when Trimebutine is combined with Eliglustat.
Pipecuronium
Vilanterol
The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Eliglustat.
Pipecuronium
Lurasidone
The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Eliglustat.
Pipecuronium
Inotersen
The risk or severity of QTc prolongation can be increased when Inotersen is combined with Eliglustat.
Pipecuronium
Pipemidic acid
The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Eliglustat.
Pipecuronium
Rufloxacin
The risk or severity of QTc prolongation can be increased when Rufloxacin is combined with Eliglustat.
Pipecuronium
Piromidic acid
The risk or severity of QTc prolongation can be increased when Piromidic acid is combined with Eliglustat.
Pipecuronium
Lorajmine
The risk or severity of QTc prolongation can be increased when Lorajmine is combined with Eliglustat.
Pipecuronium
Oxolinic acid
The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Eliglustat.
Pipecuronium
Prajmaline
The risk or severity of QTc prolongation can be increased when Prajmaline is combined with Eliglustat.